112 related articles for article (PubMed ID: 18298424)
21. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
[TBL] [Abstract][Full Text] [Related]
22. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
23. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
[TBL] [Abstract][Full Text] [Related]
24. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
Thaçi D; Reitamo S; Gonzalez Ensenat MA; Moss C; Boccaletti V; Cainelli T; van der Valk P; Buckova H; Sebastian M; Schuttelaar ML; Ruzicka T;
Br J Dermatol; 2008 Dec; 159(6):1348-56. PubMed ID: 18782319
[TBL] [Abstract][Full Text] [Related]
25. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T
Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666
[TBL] [Abstract][Full Text] [Related]
26. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of MAS063DP lotion vs 0.02% triamcinolone acetonide lotion in improving post-ablative fractional CO
Lueangarun S; Tempark T
Int J Dermatol; 2018 Apr; 57(4):480-487. PubMed ID: 29431228
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP).
Tang MB; Leong KF; Ou LS; Munasir Z; Parekh PR; Azmi S; Low WH; Goh A
J Drugs Dermatol; 2015 Feb; 14(2):169-75. PubMed ID: 25689812
[TBL] [Abstract][Full Text] [Related]
29. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
Abramovits W; Fleischer AB; Jaracz E; Breneman D
J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
[TBL] [Abstract][Full Text] [Related]
30. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
Breneman D; Fleischer AB; Abramovits W; Zeichner J; Gold MH; Kirsner RS; Shull TF; Crowe AW; Jaracz E; Hanifin JM;
J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127
[TBL] [Abstract][Full Text] [Related]
31. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis.
Aschoff R; Schwanebeck U; Bräutigam M; Meurer M
Exp Dermatol; 2009 Jan; 18(1):24-9. PubMed ID: 18637133
[TBL] [Abstract][Full Text] [Related]
32. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis.
Hebert AA; Cook-Bolden FE; Basu S; Calvarese B; Trancik RJ;
J Drugs Dermatol; 2007 Feb; 6(2):175-81. PubMed ID: 17373176
[TBL] [Abstract][Full Text] [Related]
34. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Topical Botanical Treatment of Children With Mild to Moderate Atopic Dermatitis.
Draelos ZD; Traub M; Gold MH; Green LJ; Amster M; Barak-Shinar D; Kircik LH
J Drugs Dermatol; 2019 Oct; 18(10):1038-1045. PubMed ID: 31584783
[TBL] [Abstract][Full Text] [Related]
36. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control.
Wong AW; Hon EK; Zee B
Int J Dermatol; 2008 Feb; 47(2):187-91. PubMed ID: 18211496
[TBL] [Abstract][Full Text] [Related]
37. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
[TBL] [Abstract][Full Text] [Related]
38. Treatment of atopic dermatitis with herbal combination of Eleutherococcus, Achillea millefolium, and Lamium album has no advantage over placebo: a double blind, placebo-controlled, randomized trial.
Shapira MY; Raphaelovich Y; Gilad L; Or R; Dumb AJ; Ingber A
J Am Acad Dermatol; 2005 Apr; 52(4):691-3. PubMed ID: 15793525
[TBL] [Abstract][Full Text] [Related]
39. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study.
Gueniche A; Knaudt B; Schuck E; Volz T; Bastien P; Martin R; Röcken M; Breton L; Biedermann T
Br J Dermatol; 2008 Dec; 159(6):1357-63. PubMed ID: 18795916
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea.
Amichai B; Grunwald MH
Clin Exp Dermatol; 2009 Dec; 34(8):e602-4. PubMed ID: 19486056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
